Policy and Advocacy team

We aim to influence policy developments so that researchers can be as effective as possible, and health can be improved.

We work with a wide range of partners – including governments, research funders, learned societies, charities and commercial organisations – in the UK, Europe and globally. 

Team Contacts 

Our work 

Good Clinical Trials Collaborative

Randomised clinical trials are essential to advancing evidence-based medicine and improving human health. But new guidelines are needed, which is why we've launched the Good Clinical Trials Collaborative. 

Access to healthcare interventions

Everyone should have access to the life-changing benefits of medicines and other healthcare interventions, like vaccines, diagnostics and therapies.

Open research

We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.

Brexit and the EU

Knowledge and understanding don’t stop at borders. We're working with the UK government and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.

Patient data in research

Patient data is hugely valuable for research. But the value of that data can only be unlocked if concerns about patient privacy are taken seriously.

Data Protection Regulation

The European General Data Protection Regulation was agreed in April 2016 and took effect from 25 May 2018.

EU copyright law reform

The European Commission has published a proposal to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.

Research involving animals

Almost every major breakthrough in human and veterinary medicine has depended on the use of animals to research, develop or test new therapies.

Mitochondrial donation

Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.

Expert Advisory Group on Data Access

The Expert Advisory Group on Data Access promoted good working practices, consistent governance and transparent decision making for managing and using data from cohort studies.

Accelerated Access Review

The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.

Reports 

Briefings and responses 

News